Financials
Financial year 2025
APOTHEEK HAEGEMANS - MERTENS from Herent, company number BE0433045909, closed financial year 2025 with a result of € 20,131 after tax. For that financial year APOTHEEK HAEGEMANS - MERTENS recorded a gross margin of € 73,120 and equity of € 228,654. Compared with financial year 2024, the result moved from € 15,151 to € 20,131. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ 228,654
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 20,131
▲ 33% vs 2024
Profit after tax over the fiscal year.
€ 67,705
▲ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 166,654.
People and assets in 2025
1.6
Average over the fiscal year, from the social balance sheet.
€ 48,876
▲ 7% vs 2024
€ 30,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,526
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 29,115
▲ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,585
▲ 13% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 77,334 | € 63,581 | € 64,431 | € 73,120 | ▲ 13% |
| Profit after taxes | € -12,977 | € -13,417 | € 15,151 | € 20,131 | ▲ 33% |
| Equity | € 402,147 | € 388,730 | € 208,523 | € 228,654 | ▲ 10% |
| Total debts | € 34,996 | € 32,003 | € 231,039 | € 39,768 | ▼ 83% |
| Cash | € 23,348 | € 66,837 | € 41,193 | € 67,705 | ▲ 64% |
| Land & buildings | € 5,508 | € 5,256 | € 5,005 | € 4,753 | ▼ 5% |
| Retained profit | € 340,147 | € 326,730 | € 146,523 | € 166,654 | ▲ 14% |
| Dividend | € 0 | € 0 | € 195,357 | € 0 | ▼ 100% |
| Balance sheet total | € 437,143 | € 420,733 | € 439,562 | € 268,422 | ▼ 39% |
| Employees (FTE) | 1.6 | 1.6 | 1.6 | 1.6 |
Key figures of APOTHEEK HAEGEMANS - MERTENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK HAEGEMANS - MERTENS?
What happened at APOTHEEK HAEGEMANS - MERTENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Christine Masereel stepped down as director. NBB
- Gijsen & Masereel NV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 20,131 (▲ 33% vs 2024). Source: NBB ↗
- Christine Masereel became a director. NBB
- Gijsen & Masereel NV became a director. NBB
- New establishment in Herent. KBO
- Start of the company according to the CBE. KBO
In short
From € 12,977 loss in 2022 to € 20,131 profit in 2025.
Paid € 1,205 in corporate taxes since 2022.
Best year ever: 2025, with € 20,131 profit.
On average € 45,700 of value added per employee in 2025.
A new publication or filing at APOTHEEK HAEGEMANS - MERTENS? We notify you, reason included.
Follow APOTHEEK HAEGEMANS - MERTENSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GIJSEN & MASEREEL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK HAEGEMANS - MERTENSThe shares are held by GIJSEN & MASEREEL (100%).
Directors
According to the 2025 annual accounts
since 2005 · until 2029
Managing director · represented by Rudi Gijsen
since 2005 · until 2029
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Wijgmaalsesteenweg 179A
3020 Herent
Wijgmaalsesteenweg 179
3020 Herent
Active since 10 January 1990
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0433.045.909
- VAT number
- BE 0433.045.909
- Registered office
- Wijgmaalsesteenweg 179A, 3020 Herent
- Names & denominations
- APOTHEEK HAEGEMANS - MERTENS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 December 1987
- Peppol
- Active · Active since 1 Nov 2025
- Contact
- apotheekhaegemans.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers